Found: 2
Select item for more details and to access through your institution.
Long‐term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP‐ritux.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1314, doi. 10.1002/ajh.25632
- By:
- Publication type:
- Article
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10777-w
- By:
- Publication type:
- Article